financetom
Business
financetom
/
Business
/
Ambev's Q3 Profit Jumps 8.7% Y/Y, Shares Gain On Higher Margins And Buyback
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ambev's Q3 Profit Jumps 8.7% Y/Y, Shares Gain On Higher Margins And Buyback
Oct 30, 2025 9:27 AM

Ambev SA ( ABEV ) shares traded higher on Thursday after the company reported third-quarter FY25 results.

Details

Ambev ( ABEV ) reported quarterly earnings of 24 cents per share in Brazilian Reals (4 cents per share in USD), up 8.7% year over year (Y/Y), driven by lower taxes.

The company reported quarterly sales of 20.8 billion Brazilian Real ($3.826 billion), which declined 5.7% Y/Y.

Also Read: US Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn

Normalized EBITDA, meanwhile, increased by 2.9% Y/Y organically, and margins expanded 50 basis points, led by disciplined cost and expense management and efficient resource allocation.

Segment Performance

Net revenue per hectoliter (NR/hl) grew by 7.4%, contributing to overall net revenue increases in most business units: Brazil non-alcoholic beverages (NAB) rose by 0.5%, Caribbean (CAC) by 2.2% and Latin America South (LAS) by 9.2%, while Canada and Brazil Beer saw a decline of 0.1% and 2.1%, respectively, due to volume decreases.

Organically, volumes declined 5.8% Y/Y mainly due to unseasonable weather and a challenging environment in key markets. By Segment, volumes fell in Brazil Beer (-7.7% Y/Y), Brazil NAB (-8.6% Y/Y), Canada (-2.0% Y/Y), and LAS (-0.8% Y/Y).

Other Key Metrics

The Board of Directors approved a share repurchase program of up to 208 million shares, valued at about 2.5 billion Brazilian Reals based on the October 29, 2025, closing price, to be executed over the next 18 months.

As of September 30, cash and cash equivalents (less bank overdrafts) stood at 18.31 billion Brazilian Real.

Price Action: ABEV shares are up 5.28% at $2.295 at the last check on Thursday.

Read Next:

Latin America’s Hot Stocks: 3 NYSE Picks To Dodge Trade Wars, Mideast Mayhem

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stifel Canada on kneat.com's Outlook
Stifel Canada on kneat.com's Outlook
Mar 10, 2026
02:09 PM EDT, 10/02/2025 (MT Newswires) -- kneat.com ( KSIOF ) is a SaaS company, focused in Life Sciences but also gaining traction in the MedTech space, as evident by a new contract win for a U.S. domiciled company, notes Stifel Canada. The contract is for computer systems validation and commissioning, qualification and validation at 18 manufacturing sites. We see...
Brazil poised to lead global robusta coffee farming on expansion potential, report says
Brazil poised to lead global robusta coffee farming on expansion potential, report says
Mar 10, 2026
(Reuters) -Brazil is positioning itself to overtake Vietnam as the world's largest robusta coffee producer, driven by the crop's climate resilience and growing global demand, according to a report by Dutch bank Rabobank released on Thursday.  Robusta coffee production in Brazil has grown steadily in recent years, and is estimated to reach 24.7 million 60-kg bags in 2025, according to...
Big Law rates for small firms? US appeals court takes up fee fight
Big Law rates for small firms? US appeals court takes up fee fight
Mar 10, 2026
* 9th Circuit considers whether size matters in attorney fee awards * Contract shows defense lawyers' rates in Charlie Kirk case * Firms get $19 million after antitrust win By Mike Scarcella and David Thomas Oct 2 (Reuters) - (Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to [email protected].) A U.S. appeals court...
LucyRx Completes Acquisition of CerpassRx, Strengthening Clinical Excellence and Expanding Access to Innovative Prescription Care
LucyRx Completes Acquisition of CerpassRx, Strengthening Clinical Excellence and Expanding Access to Innovative Prescription Care
Mar 10, 2026
Combination reinforces LucyRx’s proven model of client-first prescription care, expands scale, and enhances clinical depth BETHESDA, Md.--(BUSINESS WIRE)-- LucyRx, a fast-scaling, next-generation pharmacy benefits manager (PBM) known for simplifying and improving access to prescription care, today announced the completion of its acquisition of CerpassRx. The close marks another step in expanding LucyRx’s proven model of client-first, clinically forward prescription...
Copyright 2023-2026 - www.financetom.com All Rights Reserved